Thromboxane-A synthase

Preferred Label : Thromboxane-A synthase;

MeSH definition : An enzyme found predominantly in platelet microsomes. It catalyzes the conversion of PGG(2) and PGH(2) (prostaglandin endoperoxides) to thromboxane A2. EC 5.3.99.5.;

MeSH synonym : a2 synthetase, thromboxane; synthase, thromboxane a; thromboxane synthetase; synthase, thromboxane-a; thromboxane a2 synthetase; synthetase, thromboxane a2; synthetase, thromboxane; thromboxane A synthase;

MeSH CAS label : (5Z,13E)-(15S)-9alpha,11alpha-Epidioxy-15-hydroxyprosta-5,13-dienoate thromboxane-A(2)-isomerase;

MeSH Related Number : 60832-04-4 (CAS RN);

Registry Number MeSH : EC 5.3.99.5;

MeSH annotation : found in platelet microsomes;

Is substance : O;

UNII : EC 5.3.99.5;

Details

Origin ID

D013930;

UMLS CUI

C0040060;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- 1-(2,3-bis((4-methoxyphenyl)methoxy)propyl)-1H-imidazole [MeSH Supplementary Concept]
- 1-(3-benzyloxy-1(E)octenyl)imidazole [MeSH Supplementary Concept]
- 1-carboxyheptylimidazole [MeSH Supplementary Concept]
- 2,8-bis(3'-pyridylmethyl)-6H,12H-5,11-methanodibenzo(b,f)(1,5)diazocine [MeSH Supplementary Concept]
- 2-(2-(1-imidazolyl)ethyl)-4-(3-pyridyl)-1(2H)-phthalazinone [MeSH Supplementary Concept]
- 2-(2-dimethylaminoethyl)-5-benzylidene-6-methyl-3-pyridazinone [MeSH Supplementary Concept]
- 2-(4-chlorophenylsulfonamido)-6-propyl-7-((pyridin-3-yl)methyl)-1,2,3,4-tetrahydronaphthalene-5-propanoic acid [MeSH Supplementary Concept]
- 2-ethyl-4-(3-pyridyl)-1(2H)-phthalazinone [MeSH Supplementary Concept]
- 2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid [MeSH Supplementary Concept]
- 2-methyl-4-(5-thiazolyl)-1(2H)-phthalazinone [MeSH Supplementary Concept]
- 3-carbamyl-(3'-picolyl)-4-methoxy-1-benzamide [MeSH Supplementary Concept]
- 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid [MeSH Supplementary Concept]
- 4-((2-pyridinylmethyl)amino)benzoic acid [MeSH Supplementary Concept]
- 4-((3-pyridinylmethyl)amino)benzoic acid [MeSH Supplementary Concept]
- 5-chloro-1-methyl-2-(3-pyridyl)-3-indolehexanoic acid [MeSH Supplementary Concept]
- 6-(4-(2-(((4-chlorophenyl)sulfonyl)amino)ethyl)phenyl)-6-(3-pyridyl)hex-5-enoic acid [MeSH Supplementary Concept]
- 6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride [MeSH Supplementary Concept]
- 7-(4-((4-(5-(5-carboxypent-2-enyl)-4-(2-hydroxyphenyl)-1,3-dioxan-2-yl)benzyl)oxy)phenyl)-7-(3-pyridyl)hept-6-enoic acid [MeSH Supplementary Concept]
- 7-(4-(4-(((4-cyclohexylbutyl)amino)carbonyl)-2-oxazolyl)phenyl)-7-(3-pyridyl)hept-6-enoic acid [MeSH Supplementary Concept]
- 8-(benzenesulfonamido)-7-(3-pyridinyl)octanoic acid [MeSH Supplementary Concept]
- BW 149H [MeSH Supplementary Concept]
- CGS 22652 [MeSH Supplementary Concept]
- CV 6504 [MeSH Supplementary Concept]
- DTTX30 [MeSH Supplementary Concept]
- E 3040 [MeSH Supplementary Concept]
- FCE 24265 [MeSH Supplementary Concept]
- FCE 27262 [MeSH Supplementary Concept]
- ICI D1542 [MeSH Supplementary Concept]
- KDI 792 [MeSH Supplementary Concept]
- KF 13218 [MeSH Supplementary Concept]
- LG 82-4-00 [MeSH Supplementary Concept]
- LG 82-4-01 [MeSH Supplementary Concept]
- MED 27 [MeSH Supplementary Concept]
- N 0164 [MeSH Supplementary Concept]
- N-n-pentyl-N'-(2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl)urea [MeSH Supplementary Concept]
- NQ Y15 [MeSH Supplementary Concept]
- ONO AP 500-02 [MeSH Supplementary Concept]
- RS 5186 [MeSH Supplementary Concept]
- UK 34787 [MeSH Supplementary Concept]
- Y 19018 [MeSH Supplementary Concept]
- Y 20811 [MeSH Supplementary Concept]
- camonagrel [MeSH Supplementary Concept]
- cinnamophilin [MeSH Supplementary Concept]
- dazmegrel [MeSH Supplementary Concept]
- dazoxiben [MeSH Supplementary Concept]
- furegrelate [MeSH Supplementary Concept]
- imidazole [MeSH Supplementary Concept]
- isbogrel [MeSH Supplementary Concept]
- nafagrel [MeSH Supplementary Concept]
- nv 52 compound [MeSH Supplementary Concept]
- ozagrel [MeSH Supplementary Concept]
- pirmagrel [MeSH Supplementary Concept]
- ridogrel [MeSH Supplementary Concept]
- ro 22-3581 [MeSH Supplementary Concept]
- ro 22-4679 [MeSH Supplementary Concept]
- ro 23-3423 [MeSH Supplementary Concept]
- rolafagrel [MeSH Supplementary Concept]
- troeger's base [MeSH Supplementary Concept]
- wy 27569 [MeSH Supplementary Concept]
Record concept(s)
- Thromboxane-A synthase [MeSH concept]
Related MeSH Supplementary Concept(s)
- RS 86328 [MeSH Supplementary Concept]
- thromboxane synthetase deficiency [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
UMLS correspondences (same concept)
- Thromboxane synthase (substance) [SNOMED CT concept]
- thromboxane synthase [SNOMED Notion]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients